Bermuda Grass (Cyn d 1) IgE Test · Blood

If you sneeze every summer, wheeze on the golf course, or get diagnosed with a vague 'grass allergy,' you may not know which grass is actually setting off your immune system. Standard pollen extract tests can flag you as grass-allergic when you are really reacting to a sugar tag shared across many plants, not to grass at all.

This test measures antibodies against Cyn d 1, the main pollen protein from Bermuda grass. A positive result is one of the cleaner ways to confirm a true Bermuda grass allergy and to decide whether allergy shots or drops should target subtropical grasses, temperate grasses, or both.

What This Test Actually Measures

Cyn d 1 (the major group 1 allergen of Cynodon dactylon, also known as Bermuda grass) is one of the proteins your body can mistake as a threat. When that happens, your B cells make IgE (Immunoglobulin E), a class of antibody that primes your immune system to react on the next exposure.

The blood test counts the IgE antibodies that specifically lock onto Cyn d 1. A positive result reflects real sensitization to Bermuda grass pollen, not cross-reactivity to unrelated plants, and not a general 'high IgE' state. In one Chinese cohort, only about a third of patients who tested positive on a whole grass-pollen extract were actually positive to Cyn d 1, suggesting that many 'grass-positive' results on standard panels are spurious.

Why Bermuda Grass Allergy Matters

Bermuda grass blankets lawns, parks, golf courses, and sports fields across warm climates worldwide. It is one of the leading triggers of allergic rhinitis (hay fever) and a contributor to asthma in subtropical regions. Among Bermuda-sensitized adults and children in Guangzhou, China, Cyn d 1 was the most frequently recognized component, and in Tashkent 42% of respiratory allergy patients had IgE to Cyn d 1, rising to 66% among those with asthma.

The picture is similar elsewhere. In Bangkok, Bermuda grass is among the leading local sensitizers. In Australian subtropical regions, IgE to subtropical grasses like Bermuda and Bahia is more prominent than to temperate grasses such as timothy or ryegrass. Where Bermuda grass grows, Cyn d 1 IgE often drives the symptoms.

Allergic Rhinitis and Eye Symptoms

In experimental nasal allergen challenges, exposing Bermuda-sensitized adults to Bermuda grass pollen produced clear rhinitis symptoms and a rise in Bermuda grass-specific IgE alongside nasal eosinophils. In Bermuda-sensitized patients from Guangzhou, those with rhinitis had the highest Cyn d 1 positivity, around 60%. Cyn d 1 IgE behaves like a marker for the kind of grass allergy that produces sneezing, congestion, itchy eyes, and runny nose during pollen seasons.

Asthma Risk

Bermuda grass sensitization is not just a nose problem. Subtropical grass pollens including Bermuda are recognized triggers of asthma in subtropical regions, and large cohort studies show that grass pollen sensitization is part of immune patterns linked to higher asthma risk. Early-life grass and cat sensitization clusters were among the strongest predictors of later childhood asthma in a longitudinal birth cohort, and pairwise interactions between component-specific IgEs (including grass) were tied to asthma risk.

If you are Bermuda-allergic and also wheeze, get short of breath during pollen season, or have a known asthma diagnosis, confirming Cyn d 1 sensitization can change how seriously you take pollen avoidance and whether you pursue allergen immunotherapy.

Why a Component Test Beats a Standard Grass Panel

Whole pollen extracts contain many proteins plus sugar structures called cross-reactive carbohydrate determinants (CCDs). CCDs can produce IgE positivity that has little to do with real-world symptoms. In Bermuda-sensitized Chinese patients, more than half were sensitized to CCDs, which can muddy standard tests.

Cyn d 1 sidesteps much of this noise. In one comparison of Cyn d 1 IgE against Bermuda grass extract IgE, the component test was about 61% sensitive and 88% specific, with strong specificity also against Timothy grass extract (86%). The trade-off: extract panels catch more sensitizations, but component testing tells you which of those sensitizations is genuine.

Source: Li et al. 2022 (Chinese pollinosis); Liao et al. 2020 (Guangzhou Bermuda cohort); Kailaivasan et al. 2020 (Australian biogeographic study).

What this means for you: if you have grass-season symptoms and a positive grass extract IgE but no one has confirmed which grass is the real driver, a Cyn d 1 test can separate true Bermuda allergy from the background noise of cross-reactive antibodies.

How This Test Differs From Total IgE and Grass Extract IgE

Total IgE measures the overall pool of allergy antibodies in your blood. Bermuda grass extract IgE measures antibodies against any protein in a Bermuda pollen mixture, including ones shared with other plants. Cyn d 1 IgE narrows the lens to a single Bermuda-specific protein, which is why it is used to confirm primary sensitization rather than cross-reactivity.

Tracking Your Trend

A single Cyn d 1 IgE reading tells you whether you are sensitized today. What it cannot tell you is whether your sensitization is escalating, stable, or fading. Allergen-specific IgE levels can shift with seasonal pollen exposure and with treatment, so a trajectory is far more useful than a one-time number, especially when judging whether allergen immunotherapy is doing its job.

A practical cadence: get a baseline now, repeat after a full pollen season if you are unsure whether Bermuda is the culprit, and recheck 12 to 24 months into allergen immunotherapy to see how your antibody profile is shifting. If you start a biologic like omalizumab or change exposure dramatically (new climate, new home, new job outdoors), retest sooner.

What to Do With an Unexpected Result

A positive Cyn d 1 IgE in someone with seasonal nasal or chest symptoms tracking Bermuda pollen seasons is straightforward: it confirms Bermuda grass as a real allergen and supports targeted treatment. If you are positive but symptom-free, you are sensitized without clinically active allergy, which still raises your odds of developing symptoms later and is worth monitoring.

A negative Cyn d 1 result in someone with positive grass extract IgE strongly suggests your reactivity is being driven by something other than Bermuda grass, most often a temperate grass (timothy, ryegrass) or cross-reactive sugar structures. The next step is a broader component panel that includes Phl p 1 (timothy), Lol p 1 (ryegrass), profilins, and CCD markers, alongside an allergist visit if symptoms are significant. If asthma is in the picture or symptoms disrupt sleep, work, or athletic performance, escalating to an allergist or immunologist for component-resolved diagnostics and immunotherapy planning is the right move.

When Results Can Be Misleading

A few situations can shift a Cyn d 1 IgE result or make it harder to interpret.

• Cross-reactive sugar structures (CCDs): in Bermuda-sensitized Chinese patients, 52 to 88 percent were CCD-positive across age groups. CCDs can inflate IgE results to natural pollen extracts and natural Cyn d 1 preparations, though recombinant Cyn d 1 (used in most modern assays) is less affected.
• Recent or active allergen immunotherapy: specific IgE can transiently rise in the first months of immunotherapy before declining, which can confuse interpretation if you do not know when treatment started.
• Anti-IgE biologics: omalizumab and similar drugs bind free IgE, which can interfere with how specific IgE is measured depending on the assay. If you are on one of these, tell your lab and consider timing the draw before your next dose.
• Assay platform differences: point-of-care and laboratory assays for Cyn d 1 do not produce identical numbers. Substantial agreement does not mean interchangeable, so track your trend on the same assay where possible.